Yellow fever vaccine viremia following ablative BM suppression in AML

被引：8

作者：

Avelino-Silva, V. I. ^{[1
,2
]}

Leal, F. E. ^{[1
,2
,3
]}

Sabino, E. C. ^{[1
,4
]}

Nishiya, A. S. ^{[4
,5
]}

Freire, M. da Silva ^{[6
]}

Blumm, F. ^{[2
]}

Rocha, V. ^{[2
]}

Rodrigues, C. A. ^{[2
]}

Novis, Y. S. ^{[2
]}

Kallas, E. G. ^{[1
,2
,3
]}

机构：

[1] Univ Sao Paulo, Sch Med, Dept Infect & Parasit Dis, Sao Paulo, Brazil

[2] Hosp Sirio Libanes, Sao Paulo, Brazil

[3] Univ Sao Paulo, Sch Med, Div Clin Immunol & Allergy, Sao Paulo, Brazil

[4] Fundacao Prosangue Hemoctr Sao Paulo, Sao Paulo, Brazil

[5] Univ Fed Sao Paulo, Infect Dis Div DIPA, Sao Paulo, Brazil

[6] Fundacao Oswaldo Cruz, Rio De Janeiro, Brazil

来源：

BONE MARROW TRANSPLANTATION | 2013年 / 48卷 / 07期

关键词：

IMMUNE-RESPONSE; ADVERSE EVENTS; 17D; IMMUNIZATION; CHILDREN; PATIENT; BRAZIL; ASSAYS; VIRUS;

D O I：

10.1038/bmt.2012.277

中图分类号：

Q6 [生物物理学];

学科分类号：

071011 ;

摘要：

引用

页码：1008 / 1009

页数：2

共 19 条

[1] Immune response during adverse events after 17D-derived yellow fever vaccination in Europe [J].

Bae, Hi-Gung ;

Domingo, Cristina ;

Tenorio, Antonio ;

de Ory, Fernando ;

Munoz, Jose ;

Weber, Paul ;

Teuwen, Dirk E. ;

Niedrig, Matthias .

JOURNAL OF INFECTIOUS DISEASES, 2008, 197 (11) :1577-1584

[2]

Centers for Disease Control and Prevention (CDC), 2010, MMWR-MORBID MORTAL W, V59, P32

[3] Hepatitis and death following vaccination with 17D-204 yellow fever vaccine [J].

Chan, RC ;

Penney, DJ ;

Little, D ;

Carter, IW ;

Roberts, JA ;

Rawlinson, WD .

LANCET, 2001, 358 (9276) :121-122

[4] Characterization of a viscerotropic yellow fever vaccine variant from a patient in Brazil [J].

Engel, AR ;

Vasconcelos, PFC ;

McArthur, MA ;

Barrett, ADT .

VACCINE, 2006, 24 (15) :2803-2809

[5] Phenotypic and molecular analyses of yellow fever 17DD vaccine viruses associated with serious adverse events in Brazil [J].

Galler, R ;

Pugachev, KV ;

Santos, CLS ;

Ocran, SW ;

Jabor, AV ;

Rodrigues, SG ;

Marchevsky, RS ;

Freire, MS ;

Almeida, LFC ;

Cruz, ACR ;

Yamamura, AMY ;

Rocco, IM ;

da Rosa, EST ;

Souza, LTM ;

Vasconcelos, PFC ;

Guirakhoo, F ;

Monath, TP .

VIROLOGY, 2001, 290 (02) :309-319

[6] Yellow fever vaccine: a successful vaccination of an immunocompromised patient [J].

Gowda, R ;

Cartwright, K ;

Bremner, JAG ;

Green, ST .

EUROPEAN JOURNAL OF HAEMATOLOGY, 2004, 72 (04) :299-301

[7]

Kengsakul Kitisak, 2002, J Med Assoc Thai, V85, P131

[8] Adverse event reports following yellow fever vaccination [J].

Lindsey, Nicole P. ;

Schroeder, Betsy A. ;

Miller, Elaine R. ;

Braun, M. Miles ;

Hinckley, Alison F. ;

Marano, Nina ;

Slade, Barbara A. ;

Barnett, Elizabeth D. ;

Brunette, Gary W. ;

Horan, Katherine ;

Staples, J. Erin ;

Kozarsky, Phyllis E. ;

Hayes, Edward B. .

VACCINE, 2008, 26 (48) :6077-6082

[9] Standardized quantitative RT-PCR assays for quantitation of yellow fever and chimeric yellow fever-dengue vaccines [J].

Mantel, N. ;

Aguirre, M. ;

Gulia, S. ;

Girerd-Chambaz, Y. ;

Colombani, S. ;

Moste, C. ;

Barban, V. .

JOURNAL OF VIROLOGICAL METHODS, 2008, 151 (01) :40-46

[10] Fever and multisystem organ failure associated with 17D-204 yellow fever vaccination: a report of four cases [J].

Martin, M ;

Tsai, TF ;

Cropp, B ;

Chang, GJJ ;

Holmes, DA ;

Tseng, J ;

Shieh, WJ ;

Zaki, SR ;

Al-Sanouri, I ;

Cutrona, AF ;

Ray, G ;

Weld, LH ;

Cetron, MS .

LANCET, 2001, 358 (9276) :98-104

← 1 2 →